ARTICLE | Company News
FDA accepts ORPH Xyrem response
October 23, 2001 7:00 AM UTC
The FDA accepted a response from Orphan Medical (ORPH) to the July 2 approvable letter for Xyrem sodium oxybate oral solution to treat cataplexy associated with narcolepsy. The submission contains inf...